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To the Editor:—We read with interest the paper of Zulman et
al. regarding the inclusion and analysis of older adults in
randomized controlled trials
1. In a detailed cohort study of over
1500 breast cancer patients aged 65 years and older, we
applied the inclusion and exclusion criteria of the clinical trials
upon which the national breast cancer guidelines in The
Netherlands are founded. Based on age, 43% of the patients
would be excluded. Of the remaining patients, 25% would be
ineligible due to comorbid conditions and 12% because of a
history of cancer. After exclusion criteria regarding breast
cancer stage, a maximum of 12% of elderly patients could
enter the trials. Consequently, studies which do include elderly
are likely to suffer from selection bias; only elderly patients
considered ‘healthy enough’ will enter
2. Extrapolation of
results of many clinical trials to the elderly population
therefore is at least questionable.
W ea g r e ew i t ht h ea u t h o r st h a ti ti so fh i g hp r i o r i t yt o
achieve evidence in this substantial population. We doubt,
however, whether the suggestions made by the authors to
increase enrollment in clinical trials will be sufficient to fill
the ‘evidence gap’. The great heterogeneity in the elderly
population stretches the possibilities to construct random-
ized controlled clinical trials. Clinical trials might not be
equally applicable in the setting of the multiple morbidities
often seen in elderly patients: even with inclusion of very
large numbers, it remains a challenge to create homoge-
neous, comparable study arms. Therefore we stress the
importance of exploring different study designs in this ever
growing population. Restriction in research topics, design,
and analysis may give observational research the chance to
be as credible as randomized evidence
3.L a r g e ,q u a l i t y
assured prospective cohort studies generate a large amount
of reliable data. Moreover, these data are a representative
selection of the general population, including the substan-
tial heterogeneity within the elderly. International prospec-
tive registration studies (EURECCA; European Registration
of Cancer Care
4) and cancer registry collaborations (EURO-
CARE, a European cancer registry based study on survival
and care of cancer patients) may fulfill an important role in
data generation and obtaining evidence. Recently, we
initiated a detailed cohort study to study characteristics,
treatment strategies and outcome in over 2000 elderly
breast cancer patients (FOCUS: female breast cancer in
the elderly, optimizing clinical guidelines using clinico-
pathological & molecular data). Our joint efforts will
hopefully result in evidence-based medicine for elderly
(cancer) patients.
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